DSP Clinical Earns Certification as Women’s Business Enterprise (WBE) from Women’s Business Enterprise National Council (WBENC)
Leading Contract Research Organization (CRO) focuses on conducting clinical studies for small to mid-size pharmaceutical and device companies.
PARSIPPANY, New Jersey – June 3 – DSP Clinical announced it received certification as a Women’s Business Enterprise (WBE) from the Women’s Business Enterprise National Council (WBENC). DSP provides customer-focused, results-driven Contract Research Services (CRO) for Phase I-IV clinical studies for the niche market segment of small to mid-size pharmaceutical, biotechnology, and medical device companies. They are the unique alternative to the traditional larger CROs.
Founded in 1997, the WBENC is the largest third-party certifier of businesses owned, controlled, and operated by women in the US. WBENC, a national 501(c)(3) non-profit, partners with 14 Regional Partner Organizations to provide its world class standard of certification to women-owned businesses throughout the country. WBENC certifies that a business is 51% owned, controlled, operated, and managed by a woman or women.
Pamela Prince-Eason, President and CEO of the WBENC, said, “DSP exemplifies the entrepreneurial spirit that creates innovation and job opportunities in diverse industries and marketplaces. We’re pleased to welcome DSP as a WBENC-certified Women’s Business Enterprise.”
To achieve WBENC WBE Certification, DSP Clinical completed a formal documentation and site visit process which was administered by one of WBENC’s 14 Regional Partner Organizations. WBENC’s world-class certification is accepted by more than 1,000 corporations representing America’s most prestigious brands, in addition to many states, cities, and other entities. WBENC is also an approved Third Party Certifier for the United States Small Business Administration (SBA) Women-Owned Small Business (WOSB) Federal Contracting Program.
DSP President and Founder Darlene Panzitta said, “As a woman-owned organization focused on women’s health issues, we’re honored to receive this certification from the WBENC.”
Learn how DSP can bring your clinical trial in on time and on budget at the DIA Annual Conference in Boston, June 23-27, Booth #210.
About DSP Clinical
Founded in 1999, DSP Clinical is a specialty, full-service CRO that manages all aspects (study management, monitoring, risk based monitoring, data management, statistics, and medical writing) of a Phase I to IV clinical study for small to mid-size pharmaceutical, biotechnology, and device companies, with a therapeutic focus on women’s health, infertility/reproductive endocrinology, endocrinology, urology, gastroenterology and pain. DSP drives top-tier success for domestic and international clients through operational excellence, experienced staff, flexibility, passionate leadership, and a unique fixed-cost billing model. In 2012, DSP was named one of the 50 Fastest Growing Women-Owned/Led Companies in North America by the Women President’s Organization (WPO) and American Express OPEN. Visit www.dspclinical.com.
For more information on WBENC, visit www.wbenc.org.
Media contact: Brenda Nashawaty, email@example.com, 617-688-3253